Clinical Trials Directory

Trials / Completed

CompletedNCT03226561

Assessment of Near Vision Capacity in Different Light Conditions Following Bilateral Trifocal Intraocular Implantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Democritus University of Thrace · Academic / Other
Sex
All
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Patients who underwent presbyopic correction with bilateral trifocal intraocular lenses implantation are supposed to have sufficient uncorrected vision capacity for activities of daily living (ADLs) that require near vision acuity (NV), (ie. book reading). However, it is known that light intensity and temperature has a great impact on near vision capacity. Primary objective of this study is to identify the optimal task lighting conditions (in terms of light intensity and temperature) for ADLs that demand near vision acuity for a sample of patients who underwent presbyopic correction with bilateral trifocal intraocular lenses implantation

Detailed description

Patients who underwent presbyopic correction with bilateral trifocal intraocular lenses implantation are supposed to have sufficient uncorrected vision capacity for activities of daily living (ADLs) that require near vision acuity (NV), (ie. book reading). However, it is known that light intensity and temperature has a great impact on near vision capacity. Primary objective of this study is to identify the optimal task lighting conditions (in terms of light intensity and temperature) for ADLs that demand near vision acuity for a sample of patients who underwent presbyopic correction with bilateral trifocal intraocular lenses implantation. The following light intensities will be evaluated: 25, 50, and 75 foot candles. Moreover, the following light temperatures will be evaluated: 3000, 4000, and 6000 Kelvins.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhaco / PanoptixPhacoemulsification with bilateral diffractive trifocal lens implantation

Timeline

Start date
2017-07-01
Primary completion
2018-04-01
Completion
2018-06-01
First posted
2017-07-24
Last updated
2019-07-25

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT03226561. Inclusion in this directory is not an endorsement.